По вашему запросу найдено документов: 27

Страница 1 из 3

New approaches to targeted drug therapy of intracranial tumors
Beylerli, Ozal, Gareev, Ilgiz, Musaev, Elmar, Roumiantsev, Sergey, Chekhonin, Vladimir, Ahmad, Aamir, Chao, Yuan, Yang, Guang (2025)
. Emphasis is placed on the role of the BBB and BTB in modulating drug delivery and therapeutic outcomes
Сравнительный анализ клиренса лактата как предиктора послеоперационных осложнений у пожилых пациентов с метаболическим синдромом
Comparative analysis of lactate clearance as a predictor of postoperative complications in elderly patients with metabolic syndrome
Grazhdankin, Aleksandr A., Mironov, Petr I., Lutfarakhmanov, Ildar I., Гражданкин, А. А., Миронов, П. И., Лутфарахманов, И. И. (2025)
outcomes
ГИПЕРОСМОЛЯРНАЯ КОМА: ДИАГНОСТИЧЕСКИЕ СЛОЖНОСТИ НА КЛИНИЧЕСКОМ ПРИМЕРЕ
Hyperosmolar Coma: Diagnostic Difficulties on the Clinical Example
Farkhutdinova, Leila M., Фархутдинова, Л.М. (2025)
Polygenic Score Approach to Predicting Risk of Metabolic Syndrome
Timasheva, Yanina, Kochetova, Olga, Balkhiyarova, Zhanna, Korytina, Gulnaz, Prokopenko, Inga, Nouwen, Arie (2025)
.11, p = 0.507). Conclusions: Polygenic scores could aid in predicting MetS risk and health outcomes
Targeting microRNA methylation: Innovative approaches to diagnosing and treating hepatocellular carcinoma
Sufianov, Albert, Agaverdiev, Murad, Mashkin, Andrey, Ilyasova, Tatiana (2025)
personalized treatment strategies and improving patient outcomes. © 2024 The Authors
TFAP2A-regulated CRNDE enhances colon cancer progression and chemoresistance via RIPK3 interaction
Gao, Xin, Huang, Yanming, Wei, Tonghui, Xue, Jingmin, Iurii, Filippov, Yang, Laishou, Wang, Liying, Li, Hao, Mo, Genshen, Huang, Yuze, Xie, Haonan, Wang, Hang, Lou, Shenghan, Han, Peng (2025)
progression and chemoresistance, highlighting potential therapeutic targets for improving treatment outcomes
New kids on the block: MRI guided transrectal focused US, TULSA, focal laser ablation, histotripsy – a comprehensive review
Sangeet, Ghai,, Ni, Tiffany T., Pavlovich, Christian P., Futterer, Jurgen J., Schade, George R., Sanchez-Salas, Rafael, Cornud, Francois, Eggener, Scott, Feller, John F., George, Arvin K., Villers, Arnauld, de la Rosette, Jean (2025)
, demonstrating positive outcomes in oncologic control and preservation of urinary and sexual function. TULSA
Children with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results
Maniatis, Aristides K., Thornton, Paul S., Nadgir, Ulhas M., Vlachopapadopoulou, Elpis, Malievskiy, Oleg, Aghajanova, Elena M., Korpal-Szczyrska, Maria, Woods, Katie A., Mao, Meng, Zhao, Carol, Abdelrahman, Sohair G., Huang, Eric A., Komirenko, Allison S., Shu, Aimee D., Shu, A.D., Hofman, Paul (2025)
in the enliGHten trial provided robust growth outcomes and maintained a safety profile comparable
Stromal vascular fraction cell therapy: A promising therapeutic method for intracerebral hemorrhage
Gareev, Ilgiz, Beylerli, Ozal, Sufianov, Albert, Pavlov, Valentin, Shi, Huaizhang (2025)
complex pathophysiology and improving patient outcomes. This novel approach not only promises to mitigate
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
Oza, Amit M, Lisyanskaya, Alla, Fedenko, Alexander, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Kristeleit, Rebecca (2025)
and other post-progression outcomes. Methods: This open-label, randomised, controlled phase 3 trial was done

Страница 1 из 3

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год